PolyNovo Limited (ASX:PNV)
0.8750
0.00 (0.00%)
Aug 7, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 604.49 million as of August 7, 2026. Its market cap has decreased by -26.47% in one year.
Market Cap
604.49M
Enterprise Value
593.41M
Revenue
139.49M
Ranking
n/a
PE Ratio
62.18
Stock Price
0.88
ChartMarket Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 604.49M, an increase of 1,726.96%. That is a compound annual growth rate of 11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 604.49M | -28.86% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.58B |
| Imricor Medical Systems | 682.24M |
| EBR Systems | 210.89M |
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 146.87M |
| Saluda Medical | 146.17M |
| Lumos Diagnostics Holdings | 122.77M |
| SomnoMed | 92.01M |